Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rx Bandz is a medical technology company that develops the MiniJect, a next-generation, miniaturized auto-injector platform for emergency medications. The MiniJect device is designed to be the smallest and most rugged auto-injector on the market, capable of withstanding extreme conditions while remaining easy for untrained users to operate. The company's primary focus is on delivering life-saving treatments for anaphylaxis, opioid overdose, and chemical weapon exposure. Rx Bandz has secured significant partnerships with the U.S. military and various government agencies to provide portable, heat-stable drug delivery solutions. Their technology aims to replace bulky, fragile traditional injectors with a more accessible and durable alternative for both civilian and tactical use. The platform is engineered to be faster and more reliable than current market standards, ensuring critical care is delivered effectively in high-stress environments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rx Bandz.